MEDICINA
Departamento
University of Pisa
Pisa, ItaliaPublicaciones en colaboración con investigadores/as de University of Pisa (11)
2024
-
Dalbavancin real-life utilization among diabetic patients suffering from infections in Italy and Spain: The DALBADIA retrospective cohort study
Journal of Global Antimicrobial Resistance, Vol. 36, pp. 200-209
2023
-
International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab
Journal of the European Academy of Dermatology and Venereology
2021
-
SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients
Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957
2018
-
Timing of onset affects arthritis presentation pattern in antisynthetase syndrome
Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 44-49
2017
-
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study
Autoimmunity Reviews, Vol. 16, Núm. 3, pp. 253-257
-
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group
Clinical Reviews in Allergy and Immunology, Vol. 52, Núm. 1, pp. 71-80
2015
-
Clinical spectrum time course in anti jo-1 positive antisynthetase syndrome: Results from an international retrospective multicenter study
Medicine (United States), Vol. 94, Núm. 32
-
Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy
Diabetes, Obesity and Metabolism
2014
-
The PRIMARA study: A prospective, descriptive, observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice
European Journal of Endocrinology, Vol. 171, Núm. 6, pp. 727-735
2012
2004
-
Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene
Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761